Start
•Completion
Epigenetics and MDMA-Assisted Psychotherapy for PTSD
Active not recruitingRegisteredCTG
Add-on substudy (n=45) to a Phase III MDMA-assisted psychotherapy trial collecting salivary DNA at baseline and after treatment to assess epigenetic changes related to PTSD symptom change.
Details
This substudy collects saliva from participants enrolled in the parent Phase III randomized trial of MDMA-assisted psychotherapy to evaluate whether treatment-related changes occur in the epigenetic regulation of stress-associated genes.
Saliva is collected at baseline (prior to the first experimental session) and following the final experimental session (approximately 18 weeks after the first treatment) using Oragene DNA OG-500 kits for downstream analysis of salivary epithelial and white blood cell DNA.
Topics:PTSD
Registry
Registry linkNCT06189027